Fei Y, et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol. 2014;33:57–63.

Article  PubMed  Google Scholar 

Wang Z, et al. Long-term survival and death causes of systemic lupus erythematosus in China: a systemic review of observational studies. Medicine (Baltimore). 2015;94(17).

Article  PubMed  PubMed Central  Google Scholar 

Hao Y-J, et al. Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients. Eur Respir J. 2014;44:963–72.

Article  CAS  PubMed  Google Scholar 

Lin C-Y, Ko C-H, Hsu C-Y, Chen H-A. Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan. Semin Arthritis Rheum. 2020;50:957–62.

Article  PubMed  Google Scholar 

Jeon CH, et al. Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry. Int J Rheum Dis. 2012;15:e80-89.

Article  PubMed  Google Scholar 

Li M, et al. Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus. Rheumatol Immunol Res. 2021;2:43–7.

Article  PubMed  PubMed Central  Google Scholar 

Wang Z, et al. Long-term Outcomes of Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study from CSTAR Registry. Rheumatol Immunol Res. 2021;2:195–202.

Article  PubMed  PubMed Central  Google Scholar 

Galiè N, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67–119.

Article  PubMed  Google Scholar 

Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009;34:888–94.

Article  CAS  PubMed  Google Scholar 

Assad TR, et al. Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension. JAMA Cardiol. 2017;2:1361–8.

Article  PubMed  PubMed Central  Google Scholar 

Xue L, et al. Mildly Elevated Pulmonary Arterial Pressure Is Associated With a High Risk of Progression to Pulmonary Hypertension and Increased Mortality: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2021;10: e018374.

Article  PubMed  PubMed Central  Google Scholar 

Jaafar S, et al. Impact of the revised hemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis. Eur Respir J. 2019;54:1900586.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xanthouli P, et al. hemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension. Ann Rheum Dis. 2020;79:370–8.

Article  PubMed  Google Scholar 

Kolte D, et al. Mild Pulmonary Hypertension Is Associated With Increased Mortality: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2018;7: e009729.

Article  PubMed  PubMed Central  Google Scholar 

Maron BA, et al. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circulation. 2016;133:1240–8.

Article  PubMed  PubMed Central  Google Scholar 

Humbert M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2023;61:2200879.

Article  PubMed  Google Scholar 

Qian J, et al. Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study. Eur Respir J. 2019;53:1800081.

Article  CAS  PubMed  Google Scholar 

Tian X, Li M, Wang Q, Zhao J, Zeng X. The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020. Rheumatol Immunol Res. 2022;3:38–44.

Article  PubMed  PubMed Central  Google Scholar 

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.

Article  CAS  PubMed  Google Scholar 

Petri M, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677–86.

Article  PubMed  PubMed Central  Google Scholar 

Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC) et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 34, 1219–1263 (2009).

Hoeper M. M, et al. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J. 2022;60(1):2102311.

Article  PubMed  PubMed Central  Google Scholar 

Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288–91.

PubMed  Google Scholar 

Condliffe R, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2009;179:151–7.

Article  PubMed  Google Scholar 

Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982–2006. Eur Respir J. 2007;30:1103–10.

Article  CAS  PubMed  Google Scholar 

Humbert M, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173:1023–30.

Article  PubMed  Google Scholar 

Distler O, et al. Performance of DETECT PAH algorithm according to the hemodynamic definition of pulmonary arterial hypertension (PAH) in the 2022 ESC/ERS guidelines: Early detection of pulmonary arterial hypertension in systemic sclerosis patients. Arthritis Rheumatol Hoboken NJ. 2023. https://doi.org/10.1002/art.42791.

Article  Google Scholar 

Karia N, et al. Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study. Eur Heart J. 2023;44:4678–91.

Article  PubMed  PubMed Central  Google Scholar 

Qu J, et al. Predicting the Risk of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: A Chinese Systemic Lupus Erythematosus Treatment and Research Group Cohort Study. Arthritis Rheumatol Hoboken NJ. 2021;73:1847–55.

Article  CAS  Google Scholar 

Qian J, et al. Association Study Identified HLA-DQA1 as a Novel Genetic Risk of Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension. Arthritis Rheumatol Hoboken NJ. 2023;75:2207–15.

Article  CAS  Google Scholar 

Zamanian RT, et al. Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial. Am J Respir Crit Care Med. 2021;204:209–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jais X, et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum. 2008;58:521–31.

Article  PubMed  Google Scholar 

Kommireddy S, et al. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study. Rheumatol Oxf Engl. 2015;54:1673–9.

Article  CAS  Google Scholar 

Zanatta E, et al. Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment. Exp Biol Med Maywood NJ. 2019;244:120–31.

Article  CAS  Google Scholar 

Yeh F-C, et al. TLR7/8 activation induces autoimmune vasculopathy and causes severe pulmonary arterial hypertension. Eur Respir J. 2023;62:2300204.

Article  PubMed  PubMed Central  Google Scholar 

Fanouriakis A, et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2020;79:713–23.

Article  CAS  PubMed  Google Scholar 

Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 100, S1–S276 (2021).

Zhao J, et al. The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future. Pharmacol Ther. 2022;239: 108192.

Article  CAS  PubMed  Google Scholar